How GATA2 Deficiency Affects Children’s Development and Disease?
Step by step
1
Centralize GATA2 Deficiency Registry
Generate an European GATA2 genotype-phenotype database
2
Decipher
OMICs data
Genome/transcriptome architecture
Bone marrow microenvironment
Malignancy development
3
Contextualize
Patients perspectives and needs
4
Upgrade
Integrate personalized therapy and follow-up into patient care
The Project Mission
The 3D-GATA2 project mission is to unravel the mechanisms of malignant progression of GATA2 deficiency by combining a European centralised registry with multi-OMICs approaches and in vitro and in vivo modelling. This crucial data will be combined with patient perspectives with the aim of personalising therapy and patient care.
Latest News
The 3D-GATA2 project consortium gathered during the EHA 2025 Congress for a key review meeting marking the first […]
GATA-2 Team
June 24, 2025
The latest publication, authored by consortium partners Marlène Pasquet, Laetitia Largeaud, Camille Hamelle, Eric Delabesse, & Cyril Broccardo, […]
GATA-2 Team
March 25, 2025
The meeting held on 1st of March, 2024, in Toulouse, France, focused on various work packages (WP) related […]
GATA-2 Team
March 2, 2025